                Figure 6.  The predicted binding of TP5 and its alanine substitutions to HLA-DR.The key residues (E11, N62) are in red; the other contacted residues are in orange. Peptide variants correspond to A: RKDVY; B: AKDVY; C: RADVY; D: RKAVY; E: RKDAY; F: RKDVA.

